Can a closer look at bone complications in multiple myeloma improve rehabilitation?

NCT ID NCT06838065

Completed Knowledge-focused Sponsor: Azienda USL Reggio Emilia - IRCCS Source: ClinicalTrials.gov ↗

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

Multiple myeloma, a common blood cancer, often causes bone lesions that lead to pain, fractures, and other serious events. This study reviews medical records of patients diagnosed between 2019 and 2021 to describe how often these bone complications occur and what rehabilitation support they needed. The goal is to better understand the risks and guide safer, more effective rehabilitation for future patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors better predict and manage bone complications in multiple myeloma, improving rehabilitation strategies and quality of life.
What could go wrong: This is a small, retrospective study that only looks at past records, so it cannot prove cause and effect or guide treatment changes directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA (MM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE MYELOMA (MM) MULTIPLE MYELOMA BONE LESIONS

Contacts and locations

Show contact details

Locations

AUSL-IRCCS of Reggio EmiliaOperational Unit of Physical Medicine and Rehabilitation AUSL - IRCCS Reggio Emilia, Reggio Emilia, Emilia Romagna 42123

Reggio Emilia, 42123, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.